Table IV.
Correlation between the SHH, GLI TFS, and their targeted genes at the mRNA levelsa.
Genes
|
GLI2
|
GLI3
|
GLI1
|
|||
---|---|---|---|---|---|---|
Correlation results | rb | P-valueb | rb | P-valueb | rb | P-valueb |
SHH | 0.600 | <0.0001 | 0.644 | <0.0001 | 0.680 | <0.0001 |
GLI1 | 0.767 | <0.0001 | 0.894 | <0.0001 | - | - |
PTCH1 | 0.560 | 0.0002 | 0.548 | 0.0003 | 0.577 | 0.0002 |
BCL2 | 0.649 | <0.0001 | 0.517 | 0.0003 | 0.628 | <0.0001 |
MYC | 0.696 | <0.0001 | 0.600 | <0.0001 | 0.526 | 0.0002 |
VEGFA | 0.752 | <0.0001 | 0.771 | <0.0001 | 0.755 | <0.0001 |
CCND1 | 0.333 | 0.038 | 0.188 | 0.239 | 0.164 | 0.306 |
GLI TFs are placed horizontally; SHH and the affected genes are vertical.
r and P-values were calculated by Spearman's test: results with statistically significant values are indicated in bold print. SHH, sonic hedgehog; PTCH1, patched 1; GLI1,2,3, glioma-associated zinc finger protein 1, 2, 3; BCL2, BCL2 apoptosis regulator; MYC, MYC proto-oncogene; TFs, transcription factorS; VEGFA, vascular endothelial growth factor A; CCND1, cyclin D1.